FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Webinar: Next Gen Sequencing from FFPE Samples

Presented by:
Asuragen
Speakers:
Dr. Gary Latham
Hosted by:
FierceLive!

Next generation sequencing (NGS) technologies hold enormous promise to advance personalized medicine applications in cancer. However, challenging real-world tumor specimens such as FFPE and FNA specimens have not yet been carefully addressed by NGS procedures.  We developed two complementary and scalable PCR-based target enrichment methods for amplifying dozens to thousands of cancer gene loci in FFPE specimens with compatibility for both Illumina and Ion Torrent NGS. These methods enabled uniform read coverage, high depth sequencing, low background error rates, high sensitivity mutation detection, and excellent concordance with Sanger sequencing and other mutation confirmation methods. Last chance to register!